then physical dependency grows faster and the risk of addiction increases. In fact, kratom-related reports to U.S
Learn more.
Key evidence points: GLP-1 medications do not directly target or break down muscle tissue Lean mass loss occurs as a consequence of the calorie deficit and weight reduction The proportion of lean mass lost is comparable to other weight loss methods Greater absolute lean mass loss reflects the greater total weight loss achieved Regulatory bodies including NICE and the MHRA have not identified muscle loss as a specific adverse effect requiring special warnings in the Summary of Product Characteristics (SmPCs), though healthcare professionals are advised to monitor nutritional status and encourage appropriate dietary protein intake and physical activity in patients using these medications for weight management
Think of probiotics and fiber as supporting your body's own baseline GLP-1 system, not as a replacement for medication
Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes
Although a recent clinical trial failed to show significant benefit, Scott Kanoski, PhD, professor of biological sciences at University of Southern California, cautions against closing the door on this area